Cantor Fitzgerald Starts Varian Medical (VAR) at Buy; Well Positioned to Navigate Through Troubled Waters

Cantor Fitzgerald initiates coverage on Varian Medical (NYSE: VAR) with a Buy. PT $75.00.

Cantor analyst said, "We view Varian's ability to navigate through this period of uncertain hospital capital spending and reimbursement as well as European macroeconomic stress as a testment to its strong leadership, broad geographic diversity, and stellar product portfolio. TrueBeam will only
further solidify its leadership position. Despite the recent strength in shares, we would still be buyers at these levels."

For an analyst ratings summary and ratings history on Varian Medical click here. For more ratings news on Varian Medical click here.

Shares of Varian Medical closed at $64.18 yesterday.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Cantor Fitzgerald Downgrades Better Home & Finance Holding (BETR) to Neutral
• BMO Capital Resumes Snowline Gold Corp (SGD:CN) (SNWGF) at Outperform
• Cantor Fitzgerald Reiterates Overweight Rating on Applied Materials (AMAT)